GGrantIndex
Sort

51,593 grants matching hepatitis

Predicting outcomes in nonalcoholic steatohepatitis with advanced fibrosis

$534,392
Arun J Sanyal · Virginia Commonwealth University · R01 · FY2025 · DK

Inhibition of hepatic (V)LDL production by a novel antagonist of carboxyl esterase 1

$534,330
Stephen A Duncan · Medical University Of South Carolina · R01 · FY2025 · DK

CEACAM1 Alternative Splicing in Liver Ischemia-Reperfusion Injury

$534,210
Jerzy W. Kupiec-Weglinski · University Of California Los Angeles · P01 · FY2022 · AI

Diffusion of HIV-1 among Drug Using Men in SE Asia

$534,201
Michael C. Clatts · University Of Puerto Rico Med Sciences · R01 · FY2008 · DA

ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS

$534,184
Kim L Brouwer · Univ Of North Carolina Chapel Hill · R01 · FY2013 · GM

Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care

$534,162
Pedro Mateu-Gelabert · Graduate School Of Public Health And Health Policy · R01 · FY2020 · DA

Weight Loss, Inflammation, and Vascular Remodeling

$534,159
Francine K Welty · Beth Israel Deaconess Medical Center · P50 · FY2012 · HL

National Gnotobiotic Rodent Resource Center

$534,131
Ryan Balfour Sartor · Univ Of North Carolina Chapel Hill · P40 · FY2010 · RR

Quantitative Studies of Metabolic Organ Dynamics

$534,006
Richard N. Bergman · University Of Southern California · R37 · FY2009 · DK

Methods for Pathway Modeling with Application to Folate

$533,950
Duncan C. Thomas · University Of Southern California · R01 · FY2014 · ES

Studies on RNAi Based Delivery in Vivo

$533,921
Mark A Kay · Stanford University · R01 · FY2012 · DK

Atlanta Center for the Childhood Liver Disease Research Network (ChiLDReN)

$533,918
Saul Joseph Karpen · Emory University · U01 · FY2020 · DK

Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China

$533,855
Scott L Letendre · University Of California, San Diego · R01 · FY2011 · MH

Protective role of OPN-High macrophages in NASH

$533,838
Natalia Nieto · University Of Illinois At Chicago · R01 · FY2023 · DK

Endocrine-immune-reproductive System Interactions

$533,831
Tomoshige Kino · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD

PFAS increases susceptibility to infection-mediated PTB

$533,723
Michael Curtis Petriello · Wayne State University · R01 · FY2024 · ES

Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs

$533,698
Bruce R Schackman · Weill Medical Coll Of Cornell Univ · R01 · FY2009 · DA

Epigenetic Plasticity of HCV-Specific CD8 T Cells after Antiviral Therapy

$533,673
William Nicholas Haining · Massachusetts General Hospital · U19 · FY2016 · AI

Chlamydial Vaccine Testing in Mice and Guinea Pigs

$533,605
Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U19 · FY2021 · AI

Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis

$533,499
Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2022 · DK

Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression

$533,446
Klaus H. Kaestner · University Of Pennsylvania · R01 · FY2022 · CA

Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression

$533,446
Klaus H. Kaestner · University Of Pennsylvania · R01 · FY2023 · CA

New Targets of Thyroid Hormone Action

$533,374
Anthony N Hollenberg · Beth Israel Deaconess Medical Center · R01 · FY2013 · DK

Management of Pediatric Type 2 Diabetes Mellitus

$533,366
Lorraine E Katz · Children'S Hosp Of Philadelphia · U01 · FY2007 · DK

Novel effectors of insulin action in the liver

$533,354
Fajun James Yang · Albert Einstein College Of Medicine · R01 · FY2023 · DK